News

1. Recipham To Expand Lyophilization Capacity With €32M Investment In Germany 10/8/2013

   Recipharm has recently announced an investment of €32M in its Wasserburg site located near Munich.

2. OsoBio Appoints Lindsey Pruitt To Manage East Coast Business Development Efforts 7/22/2013

   OsoBio has named Lindsey Pruitt manager of new business development for its East Coast market.

3. OsoBio Appoints David M. Lee Vice President Of Quality 5/13/2013

   OsoBio has named David M. Lee vice president of quality.

   Lee is responsible for overseeing all quality-related functions to ensure the company’s continued compliance with Current Good Manufacturing Practices (cGMP), including quality systems, quality control and manufacturing quality assurance.

   Lee brings to his role more than 20 years of professional experience managing quality operations and API and sterile manufacturing.

4. Vetter's New Commercial Filling Line Ready For cGMP Filling 4/18/2013

   Vetter, a leading contract development and manufacturing organization (CDMO), announced today that its new award-winning filling line at the company’s Ravensburg Vetter South facility is fully validated and ready for cGMP filling, after successful media-fill completion. One customer project is underway, with more in the wings. The line’s capacity ranges from mid- to large-volume batch sizes, with a maximum filling speed of 800 pre-sterilized syringes per minute. The line currently fills 1ml standard-format syringes, with additional formats to be added in the near and long terms. Featuring novel technologies that enhance safety and maximize API yield, it was designed to exceed cGMP requirements.

5. Vetter Offers Answers For The Future At The Pharma Congress 2013 2/19/2013

   Changing markets and potential solutions will be the highlight at the 15th Pharma Congress Production & Technology in Duesseldorf, Germany, March 19 - 20. Vetter, one of the worlds’ leading Contract and Development Manufacturing Organization, will present on a variety of informative core developments critical to the international pharmaceutical and biotech industries.

6. Pfenex Inc. Awards Althea Technologies A Contract For cGMP Manufacturing Of Circumsporozoite Protein From Plasmodium Falciparum, A Key Malaria Antigen 10/24/2012

   Pfenex Inc. recently announced that it has awarded Althea Technologies a contract for the current Good Manufacturing Practice (cGMP) manufacturing of circumsporozoite protein (CSP) from Plasmodium falciparum, an important and proven component of an effective malaria vaccine.

7. Vetter Receives Top Prize At The European Outsourcing Awards Ceremony 10/15/2012

   Vetter has been awarded first place for the category Most Improved Manufacturing Project or Process at this year’s European Outsourcing Awards. The application for the company’s new high-speed filling line for pre-sterilized syringes was the top choice among the jury of experts due to its intelligent concepts and systems. The award was given to the company at a gala dinner on October 10, during the CPHI Worldwide/iCSE show in Madrid.

8. Symbiosis Launches Multi-Million Pound Sterile Drug Manufacturing Capability In Scotland 10/9/2012

   Symbiosis Pharmaceutical Services Limited, an MHRA-approved sterile manufacturing facility based in Stirling, Scotland is an exciting, young company specializing in the small-scale manufacture of sterile pharmaceuticals for clinical trials (fill/finish).

9. JHP Pharmaceuticals To Produce Lyophilized Biologic For International Late-Phase Clinical Trials 9/19/2012

   JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile products has entered into an agreement with an undisclosed pharmaceutical company to produce supplies of a lyophilized biologic for international, late-phase clinical trials.

10. JHP Pharmaceuticals Enters Agreement To Produce Diagnostic Aid 10/18/2011

    JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile injectable products announced today that it has entered into an agreement with an undisclosed pharmaceutical company for the product transfer and registration batch production of a diagnostic aid.